Search | Browse by Day | Author Index

Author Index: S

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Saarimaki, A.
  • EVALUATING AN H1N1 DECISION AID FOR FAMILIES
    • Sachs, G. A.
  • IMPACT OF QUANTITATIVE INFORMATION AND A NUDGE ON ATTITUDES TOWARD COLORECTAL CANCER SCREENING
    • Sadatsafavi, M.
  • COMPREHENSIVE EVIDENCE SYNTHESIS AND TRIAL-BASED COST-EFFECTIVENESS ANALYSIS: CAN THEY BE COMFORTABLE BED FELLOWS?
    • Sadesky, N.
  • COMPARATIVE EFFECTIVENESS RESEARCH: ERECTILE DYSFUNCTION LONGITUDINAL OUTCOMES AND COSTS ACROSS TREATMENTS FOR PROSTATE CANCER
    • Sadique, Z.
  • ESTIMATING SUBGROUP EFFECTS IN COST-EFFECTIVENESS ANALYSES (CEA): A COMPARISON OF METHODS
    • Saginur, R.
  • CAN IPDAS CRITERIA BE USED TO ASSESS THE QUALITY OF INFORMED CONSENT DOCUMENTS?
    • Said, A.
  • OPTIMAL COLONOSCOPY SCREENING POLICIES FOR COLORECTAL CANCER PREVENTION AND SURVEILANCE
    • Sakai, M.
  • DEVELOPMENT OF DECISION SUPPORT SYSTEM FOR SUBJECTS TESTED POSITIVE FOR CANCER
    • Sakaida, I.
  • THE IMPACT OF TUMOR KINETIC GROWTH MODELS ON THE COST-EFFECTIVENESS OF PERIODIC SURVEILLANCE FOR HEPATOCELLULAR CARCINOMA
    • Samiedaluie, S.
  • CLINICAL DECISION MAKING FOR PREVENTION OF STROKE FROM ATRIAL FIBRILLATION
    • Sanchez Chaparro, M. A.
  • IMPROVING DIAGNOSIS: STARTING A LOCAL STRATEGY
    • Sander, B.
  • IS A MASS IMMUNIZATION PROGRAM FOR PANDEMIC (H1N1) 2009 GOOD VALUE FOR MONEY? EVIDENCE FROM THE CANADIAN EXPERIENCE
  • INTRODUCTION TO INFECTIOUS DISEASE TRANSMISSION MODELS
    • Sanders, G. D.
  • COST-EFFECTIVENESS OF NOVEL ANTIRETROVIRALS FOR HUMAN IMMUNODEFICIENCY VIRUS INFECTION
    • Sansgiry, S. S.
  • COST-EFFECTIVENESS ANALYSIS OF DULOXETINE AND VENLAFAXINE EXTENDED RELEASE FOR THE TREATMENT OF GENERALIZED ANXIETY DISORDER (GAD)
    • Sansom, S.
  • HIV PARTNER SERVICES: WHEN IS IT WORTH THE ADDITIONAL COST?
    • Saposnik, G.
  • ECONOMIC EVALUATION OF GENETIC TEST IN COMBINATION WITH PREVENTIVE DONEPEZIL TREATMENT FOR AMNESTIC MILD COGNITIVE IMPAIRMENT (AMCI) PATIENTS
    • Sax, P. E.
  • THRESHOLDS FOR COST-EFFECTIVENESS OF ADDING AN AGENT THAT IMPROVES IMMUNE RESPONSES TO INITIAL ANTIRETROVIRAL THERAPY (ART) IN HIV-INFECTED PATIENTS: GUIDANCE FOR DRUG DEVELOPMENT
    • Scales, Jr., C. D.
  • ARE THERE GAINS IN COST-EFFECTIVENESS OF CHEMOPREVENTION FOR PROSTATE CANCER WHEN TARGETING MEN AT HIGHER RISK BASED ON FAMILY HISTORY AND GENETIC RISK MARKERS?
    • Scales, D. C.
  • IS A MASS IMMUNIZATION PROGRAM FOR PANDEMIC (H1N1) 2009 GOOD VALUE FOR MONEY? EVIDENCE FROM THE CANADIAN EXPERIENCE
    • Schackman, B. R.
  • THRESHOLDS FOR COST-EFFECTIVENESS OF ADDING AN AGENT THAT IMPROVES IMMUNE RESPONSES TO INITIAL ANTIRETROVIRAL THERAPY (ART) IN HIV-INFECTED PATIENTS: GUIDANCE FOR DRUG DEVELOPMENT
    • Schaefer, A.
  • MARKOV DECISION PROCESSES - ANALYTIC METHODS FOR SEQUENTIAL DECISIONS
  • OPTIMAL STRAIN SELECTION FOR THE ANNUAL INFLUENZA VACCINE UNDER THE CLOSEST ANTIGENIC DISTANCE IMMUNITY MODEL
    • Schaefer, A. J.
  • ELICITING PATIENTS' REVEALED PREFERENCES: AN INVERSE MARKOV DECISION PROCESS APPROACH
  • WHEN SHOULD END-STAGE LIVER DISEASE (ESLD) PATIENTS UPDATE THEIR MODEL FOR END-STAGE LIVER DISEASE (MELD) SCORE?
  • THE OPTIMAL TIMING OF PREDIALYSIS PREARRANGED PAIRED KIDNEY EXCHANGES
  • OPTIMAL LIVER ACCEPTANCE POLICIES FOR RISK-SENSITIVE PATIENTS
    • Schapira, M.
  • DECISION MAKERS' PERCEPTIONS OF DECISION MODELS: A CASE STUDY
  • EXPECTATIONS AND SATISFACTION AFTER ELECTIVE CERVICAL SPINE SURGERY FOR DEGENERATIVE CONDITIONS
  • THE NUMERACY UNDERSTANDING IN MEDICINE INSTRUMENT (NUMI): A NEW MEASURE OF HEALTH NUMERACY DEVELOPED USING ITEM RESPONSE THEORY
    • Schauer, C.
  • THE NUMERACY UNDERSTANDING IN MEDICINE INSTRUMENT (NUMI): A NEW MEASURE OF HEALTH NUMERACY DEVELOPED USING ITEM RESPONSE THEORY
    • Schechter, C.
  • CANCER SCREENING DECISIONS AND POLICY: WHEN MIXED EVIDENCE MEETS STRONG PREFERENCES
    • Schechter, M. T.
  • THE COST-EFFECTIVENESS OF HEROIN ASSISTED TREATMENT FOR CHRONIC, TREATMENT-REFRACTORY OPIOID ADDICTS
    • Schiff, G.
  • RESEARCH METHODS PANEL DISCUSSION: IS THERE A RIGHT WAY FORWARD?
    • Schneider, K.
  • ECONOMIC EVALUATION OF MONITORING VIROLOGIC RESPONSES TO ANTIRETROVIRAL THERAPY IN HIV-INFECTED CHILDREN IN RESOURCE-LIMITED SETTINGS
    • Schoenbaum, M.
  • A MODELED ECONOMIC EVALUATION OF ALTERNATIVE STRATEGIES TO REDUCE SUDDEN CARDIAC DEATH IN YOUNG ATHLETES
    • Schonberg, M.
  • BREAST CANCER TREATMENT DECISIONS AMONG WOMEN AGED 80 AND OLDER
    • Schuelke, M. J.
  • CHANGES IN STRUCTURE OF DIAGNOSIS KNOWLEDGE DUE TO A CHEST PAIN DIAGNOSIS TUTORIAL
    • Schull, M. J.
  • RESEARCH METHODS PANEL DISCUSSION: IS THERE A RIGHT WAY FORWARD?
    • Schulman, K. A.
  • ARE THERE GAINS IN COST-EFFECTIVENESS OF CHEMOPREVENTION FOR PROSTATE CANCER WHEN TARGETING MEN AT HIGHER RISK BASED ON FAMILY HISTORY AND GENETIC RISK MARKERS?
    • Schultz, R. I.
  • DELAYED DIAGNOSIS OF APPENDICITIS IN AN AML PATIENT
    • Schwartz, A.
  • CONTRACEPTIVE DECISIONAL CONFLICT: A QUALITATIVE ANALYSIS APPLYING THE OTTAWA DECISION SUPPORT FRAMEWORK TO ASSESS DETERMINANTS OF CONTRACEPTIVE DECISIONS
  • CONCURRENT ORAL SESSION I: SJDM JOINT SESSION
  • MDM 101: COMMON MDM METHODS AND APPLICATIONS
    • Schwartz, G. N.
  • SHARED DECISION MAKING FOR WOMEN WITH BREAST CANCER: KNOWLEDGE, VALUES, AND DECISIONAL CONFLICT OVER TIME
    • Schwartz, G.
  • COST-EFFECTIVENESS ANALYSIS OF 48- VERSUS 24-HOUR METHYLPREDNISOLONE INTERVENTION IN SPINAL CORD INJURY PATIENTS
    • Schwartz, J. S.
  • CANCER SCREENING DECISIONS AND POLICY: WHEN MIXED EVIDENCE MEETS STRONG PREFERENCES
    • Schwartz, L. M.
  • A QUALITATIVE REVIEW OF DIFFERENTIAL DIAGNOSIS GENERATORS
    • Schwartz, P. H.
  • IMPACT OF QUANTITATIVE INFORMATION AND A NUDGE ON ATTITUDES TOWARD COLORECTAL CANCER SCREENING
    • Schwarzer, R.
  • IQWIG'S EFFICIENCY FRONTIER APPROACH FOR ECONOMIC EVALUATION IN GERMANY - A PILOT AND FEASIBILITY STUDY ON HEPATITIS C TREATMENT
    • Schwarzinger, M.
  • COST-EFFECTIVE ALTERNATIVES TO LIVER BIOPSY IN THE MANAGEMENT OF CHRONIC HEPATITIS C
    • Sciacovelli, L.
  • LABORATORY ERRORS AND PATIENT SAFETY: THE IFCC WORKING GROUP PROJECT
    • Scott, C.
  • THRESHOLDS FOR COST-EFFECTIVENESS OF ADDING AN AGENT THAT IMPROVES IMMUNE RESPONSES TO INITIAL ANTIRETROVIRAL THERAPY (ART) IN HIV-INFECTED PATIENTS: GUIDANCE FOR DRUG DEVELOPMENT
  • A COST-EFFECTIVENESS ANALYSIS OF GENOTYPE DRUG RESISTANCE TESTING AT FAILURE OF 1ST-LINE ANTIRETROVIRAL THERAPY IN HIV-INFECTED PATIENTS IN SOUTH AFRICA
    • Sculpher, M.
  • COST-EFFECTIVENESS OF NOVEL ANTIRETROVIRALS FOR HUMAN IMMUNODEFICIENCY VIRUS INFECTION
  • NICE DECISION MAKING
    • Sekhon, J. S.
  • ESTIMATING SUBGROUP EFFECTS IN COST-EFFECTIVENESS ANALYSES (CEA): A COMPARISON OF METHODS
    • Sepucha, K. R.
  • TREATING HIP AND KNEE OSTEOARTHRITIS: DO PATIENTS WHO CHOOSE SURGERY MAKE BETTER DECISIONS?
  • CHALLENGES TO NUMERACY ASSESSMENT AND RISK COMMUNICATION IN AN UNDERSERVED POPULATION
    • Seth, M.
  • ASSESSING THE IMPACT OF AN IMPERFECT REFERENCE STANDARD ON ROC ANALYSIS THROUGH SIMULATION
    • Severens, H.
  • IMPLEMENTING GUIDELINES INTO CLINICAL PRACTICE: WHAT IS THE VALUE?
    • Shachter, R.
  • MUTUAL INFORMATION ANALYSIS USED TO DETERMINE MOST INFORMATIVE FEATURES IN BREAST CANCER DIAGNOSIS
    • Shaffer, B.
  • COST EFFECTIVENESS OF ANTENATAL STEROIDS IN LATE PRETERM PREGNANCIES
    • Shaffer, V. A.
  • UNDERSTANDING THE INFLUENCE OF PATIENT NARRATIVES IN A DECISION AID FOR EARLY STAGE BREAST CANCER
    • Shah, N. D.
  • MEASURING THE BENEFIT OF PSA SCREENING FROM THE PATIENT AND SOCIETAL PERSPECTIVES
  • CONCURRENT ORAL SESSION H: HEALTH SERVICES AND POLICY RESEARCH
  • EVALUATING THE IMPACT OF OPTIMAL MANAGEMENT FOR PATIENTS WITH TYPE 2 DIABETES
    • Shamliyan, T. A.
  • HOW MUCH NEGATIVE MARGIN IS ENOUGH FOR PATIENTS WITH DUCTAL CARCINOMA IN SITU RECEIVING BREAST CONSERVING SURGERY WITH OR WITHOUT RADIOTHERAPY? A BAYESIAN META-ANALYSIS
    • Shane, A. L.
  • THE IMPACT OF MASS CHANGES IN SOCIAL MIXING PATTERNS ON THE COURSE OF AN INFLUENZA PANDEMIC
    • Shaw, C.
  • THE A6 CYCLE: A METHOD FOR IDENTIFYING EVIDENCE-BASED LABORATORY MEDICINE BEST PRACTICES AND A TECHNOLOGY ASSESSMENT VALIDATION
    • Shen, Y.
  • POTENTIAL IMPACT ON DIABETES AND CARDIOVASCULAR DISEASES FROM A ONE-PENNY-PER-OUNCE EXCISE TAX ON SUGAR-SWEETENED BEVERAGES
    • Shepherd, H. L.
  • THREE SIMPLE QUESTIONS TO IMPLEMENT EVIDENCE-BASED PRACTICE AND INCREASE PATIENT INVOLVEMENT
    • Shepherd, J. P.
  • INTERSTIM® SACRAL NEUROMODULATION AND BOTOX® BOTULINUM-A TOXIN INTRADETRUSOR INJECTIONS FOR REFRACTORY URGE URINARY INCONTINENCE: A DECISION ANALYSIS COMPARING OUTCOMES INCLUDING EFFICACY AND COMPLICATIONS
    • Sheridan, S.
  • CONJOINT ANALYSIS VS. RATING AND RANKING FOR VALUES CLARIFICATION IN COLORECTAL CANCER SCREENING
    • Shi, P.
  • THE IMPACT OF MASS CHANGES IN SOCIAL MIXING PATTERNS ON THE COURSE OF AN INFLUENZA PANDEMIC
    • Shimbo, T.
  • DEVELOPMENT OF DECISION SUPPORT SYSTEM FOR SUBJECTS TESTED POSITIVE FOR CANCER
    • Shojania, K.
  • CAN IPDAS CRITERIA BE USED TO ASSESS THE QUALITY OF INFORMED CONSENT DOCUMENTS?
    • Showalter, J.
  • THE EFFECT OF A PHYSICIAN-ENHANCED CLINICAL DECISION SUPPORT TOOL FOR GUIDING VENOUS THROMBOEMBOLISM PHARMACOPROPHYLAXIS IN LOW-RISK PATIENTS
    • Siebert, U.
  • MICROSIMULATION METHODS AND THEIR APPLICABILITY IN THE EVALUATION OF PERSONALIZED MEDICINE STRATEGIES
  • CONCURRENT ORAL SESSION J: GLOBAL HEALTH AND PREFERENCES
  • MODELING APPROACHES FOR ANALYSING HEALTH CARE PROBLEMS – AN INTRODUCTORY OVERVIEW AND COMPARISON
  • IQWIG'S EFFICIENCY FRONTIER APPROACH FOR ECONOMIC EVALUATION IN GERMANY - A PILOT AND FEASIBILITY STUDY ON HEPATITIS C TREATMENT
  • CAUSAL INFERENCE AND CAUSAL DIAGRAMS IN MEDICAL DECISION MAKING
    • Siegel, J.
  • DECISION MAKERS' PERCEPTIONS OF DECISION MODELS: A CASE STUDY
    • Siemens, R.
  • THE IMPACT OF VALUES CLARIFICATION IN A DECISION AID: EVIDENCE FROM A RANDOMIZED CONTROLLED TRIAL EMERGES SLOWLY OVER TIME
    • Sieminowski, T.
  • FORECASTING FUNCTIONAL GAINS PLATEAU FOR NEUROREHABILITATION PATIENTS
    • Sievert, M.
  • HOSPITAL LIBRARIES INFLUENCE PATIENT CARE: SURVEY RESULTS FROM 4 HOSPITALS
    • Sikich, N.
  • A SYSTEMATIC REVIEW AND META-ANALYSIS OF SURVIVAL CURVE DATA TO DETERMINE THE EFFECTIVENESS OF LIVER AND KIDNEY TRANSPLANTATION IN PERSONS WITH END-STAGE ORGAN FAILURE AND HUMAN IMMUNODEFICIENCY VIRUS
    • Silliman, R.
  • BREAST CANCER TREATMENT DECISIONS AMONG WOMEN AGED 80 AND OLDER
    • Silman, M. S.
  • ETHICAL AND RISK COMMUNICATION DILEMMAS FACED BY DECISION MAKERS DURING THE H1N1 2009 PANDEMIC: A MIXED METHODS ANALYSIS
    • Siminovitch, K.
  • ECONOMIC EVALUATION OF GENETIC TEST IN COMBINATION WITH PREVENTIVE DONEPEZIL TREATMENT FOR AMNESTIC MILD COGNITIVE IMPAIRMENT (AMCI) PATIENTS
    • Simon, C.
  • RISK AND UNCERTAINTY: SHIFTING DECISION-MAKING FOR ANEUPLOIDY SCREENING TO THE FIRST TRIMESTER OF PREGNANCY
    • Simons, C.
  • DO MEN SCHEDULING A PROSTATE BIOPSY BENEFIT FROM INFORMATION ABOUT POTENTIAL TREATMENT OPTIONS?
    • Simons, E.
  • ORAL IMMUNOTHERAPY COMPARED WITH STANDARD AVOIDANCE OF COW MILK PROTEIN AMONG CHILDREN WITH COW MILK ALLERGY: A DECISION ANALYSIS
    • Singer, J.
  • COST-EFFECTIVENESS ANALYSIS OF A RANDOMIZED TRIAL COMPARING CARE MODELS FOR CHRONIC KIDNEY DISEASE
    • Singer, M. E.
  • DEVELOPING A VALID METHOD OF PREDICTING RETURNING TO WORK FOLLOWING PRIMARY TOTAL KNEE ARTHROPLASTY
    • Singh, H.
  • RESEARCH METHODS PANEL DISCUSSION: IS THERE A RIGHT WAY FORWARD?
    • Singh, S. R.
  • USING MIXED TREATMENT COMPARISONS TO GENERATE RECOMMENDATIONS FOR OPTIMAL USE OF MEDICATIONS
    • Singhal, G.
  • A WEB-BASED “DIAGNOSTICIAN 101” LEARNING MODULE: TEACHING COGNITIVE STRATEGIES TO REDUCE DIAGNOSTIC ERRORS
    • Sinicrope, P. S.
  • PERSONALIZED PREVENTIVE MEDICINE AND ITS CONSEQUENCES: THE IMPACT OF PREDICTIVE GENOMIC TESTING ON RISK PERCEPTION AND WORRY
    • Skedgel, C.
  • SOCIETAL PREFERENCES IN THE ALLOCATION OF HEALTHCARE RESOURCES: AN EMPIRICAL ETHICS APPROACH
    • Skye, A.
  • FOUNDATIONAL KNOWLEDGE IMPROVES LEARNING IN A SIMULATED CLINICAL TRAINING SCENARIO
    • Slutsky, J. R.
  • HEALTH TECHNOLOGY ASSESSMENT AROUND THE WORLD: HIGH AND LOW RESOURCE SETTINGS, LIBERTARIAN
    • Smart, K. A.
  • THE COST-EFFECTIVENESS OF PALIVIZUMAB: A SYSTEMATIC REVIEW OF THE EVIDENCE
    • Smets, E. M.
  • COMMUNICATION ABOUT CANCER PATIENTS' APPRAISAL OF TREATMENT ASPECTS AND ALTERNATIVES: AN EXPLORATIVE STUDY
    • Smith, D.
  • INFORMATION OVERLOAD IN BREAST CANCER DECISION MAKING: WHEN TWO CHOICES ARE TOO MANY
    • Smith, K.
  • PROBABILITY OF SUCCESS WITH LAPAROSCOPIC VERSUS HYSTEROSCOPIC STERILIZATION
  • THE COST-EFFECTIVENESS OF THREE REFERRAL STRATEGIES FOR ACUTE LOW BACK PAIN IN THE PRIMARY CARE SETTING
  • COST-EFFECTIVENESS OF COMBINED INFLUENZA AND PNEUMOCOCCAL VACCINATION: IS IT THE RIGHT TIME?
  • COST-EFFECTIVENESS OF SEXUAL ASSAULT PREVENTION PROGRAMS: POTENTIAL UTILITY OF TARGETED TREATMENT FOR HIGH-RISK MEN
  • COST-EFFECTIVENESS OF DRONEDARONE COMPARED TO AMIODARONE FOR PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION
  • INTERSTIM® SACRAL NEUROMODULATION AND BOTOX® BOTULINUM-A TOXIN INTRADETRUSOR INJECTIONS FOR REFRACTORY URGE URINARY INCONTINENCE: A DECISION ANALYSIS COMPARING OUTCOMES INCLUDING EFFICACY AND COMPLICATIONS
  • COST CONSCIOUSNESS IN MEDICINE – CURRENT LEVEL OF RESIDENT AWARENESS AND NEED FOR EDUCATION
  • DECISION MODEL: FACTOR V LEIDEN AND ANTICOAGULATION DURATION
    • Smith, S. G.
  • CLINICAL UNCERTAINTY AND RISK AVERSION ARE ASSOCIATED WITH PRIMARY CARE PROVIDER REFERRAL OF PATIENTS WITH SEVERE KIDNEY DISEASE TO NEPHROLOGY
    • Smith, S.
  • EVALUATING THE IMPACT OF OPTIMAL MANAGEMENT FOR PATIENTS WITH TYPE 2 DIABETES
    • Smith-Spangler, C. M.
  • IS THERE A DIFFERENCE BETWEEN ORGANIC AND CONVENTIONAL ANIMAL PRODUCTS? A SYSTEMATIC REVIEW OF THE HEALTH BENEFITS AND HARMS
  • CARE COORDINATION: WHAT WORKS? MAKING SENSE OF A VAST LITERATURE VIA A SYSTEMATIC REVIEW OF REVIEWS
  • HEALTH INSURANCE, CATASTROPHIC MEDICAL SPENDING, AND DIABETES TREATMENT IN DEVELOPING COUNTRIES
  • IS THERE A DIFFERENCE BETWEEN ORGANICALLY AND CONVENTIONALLY GROWN PRODUCE? A SYSTEMATIC REVIEW OF THE HEALTH BENEFITS AND HARMS
    • Smyth, K. A.
  • DEVELOPING A VALID METHOD OF PREDICTING RETURNING TO WORK FOLLOWING PRIMARY TOTAL KNEE ARTHROPLASTY
    • Snyder, S. R.
  • THE A6 CYCLE: A METHOD FOR IDENTIFYING EVIDENCE-BASED LABORATORY MEDICINE BEST PRACTICES AND A TECHNOLOGY ASSESSMENT VALIDATION
    • Soares, M.
  • GENERATING AND USING ELICITED EVIDENCE FOR DECISION MODELS
    • Solli, O.
  • COST-EFFECTIVENESS OF INTENSIVE LIFESTYLE INTERVENTION IN PATIENTS WITH POORLY CONTROLLED TYPE 2 DIABETES
    • Soltys, G.
  • COST-EFFECTIVENESS ANALYSIS OF A RANDOMIZED TRIAL COMPARING CARE MODELS FOR CHRONIC KIDNEY DISEASE
    • Soroka, S.
  • COST-EFFECTIVENESS ANALYSIS OF A RANDOMIZED TRIAL COMPARING CARE MODELS FOR CHRONIC KIDNEY DISEASE
    • Sousa, K.
  • INFLUENCES ON PHYSICIANS' ASSESSMENTS AND DECISIONS REGARDING PRESCRIPTION DRUG EFFECTIVENESS
    • Spackman, D. E.
  • UNIFYING RESEARCH AND REIMBURSEMENT DECISIONS: A FRAMEWORK AND ALGORITHM FOR POLICY CHOICE
  • THE COMPARATIVE EFFECTIVENESS OF BIOMARKERS FOR ALZHEIMER DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
    • Spiess, P.
  • PROSTATE CANCER SCREENING CONTROVERSY: A CHALLENGE FOR DECISION AIDS FOR MEN AT HIGH RISK
    • Sprang, G.
  • ETHICAL AND RISK COMMUNICATION DILEMMAS FACED BY DECISION MAKERS DURING THE H1N1 2009 PANDEMIC: A MIXED METHODS ANALYSIS
    • Spratt, K. F.
  • GOALS, SYMPTOMS, SIGNS, AND TREATMENTS AMONG WOMEN WITH PELVIC FLOOR DISORDERS
    • Spronk, S.
  • PERSONALIZED PREVENTION OF CORONARY ARTERY DISEASE
  • DO DIFFERENT METHODS OF MODELING STATIN EFFECTIVENESS INFLUENCE THE OPTIMAL DECISION?
    • Sroczynski, G.
  • MICROSIMULATION METHODS AND THEIR APPLICABILITY IN THE EVALUATION OF PERSONALIZED MEDICINE STRATEGIES
  • IQWIG'S EFFICIENCY FRONTIER APPROACH FOR ECONOMIC EVALUATION IN GERMANY - A PILOT AND FEASIBILITY STUDY ON HEPATITIS C TREATMENT
    • Stacey, D.
  • SHARED DECISION MAKING BEHAVIOURS IN FAMILY MEDICINE RESIDENTS
    • Stahl, J.
  • MDM 101: COMMON MDM METHODS AND APPLICATIONS
  • MODELING APPROACHES FOR ANALYSING HEALTH CARE PROBLEMS – AN INTRODUCTORY OVERVIEW AND COMPARISON
  • INTRODUCTION TO DISCRETE-EVENT SIMULATION FOR HEALTHCARE
    • Stasiulis, E.
  • DECISION MAKING IN THE MANAGEMENT OF CHILDREN HOSPITALIZED WITH ACUTE IMMUNE THROMBOCYTOPENIC PURPURA: UNDERSTANDING CHILD, PARENT, AND HEALTH CARE PROFESSIONAL PERSPECTIVES
  • EXPLORING THE EXPERIENCE OF ACUTE IMMUNE THROMBOCYTOPENIC PURPURA THROUGH NARRATIVES OF CHILDREN WITH IMMUNE THROMBOCYTOPENIC PURPURA, THEIR PARENTS, AND HEALTH CARE PROFESSIONALS
    • Stavem, K.
  • TESTING THE ACCURACY OF COMPOSITE HEALTH STATE UTILITY ESTIMATORS – AN ANALYSIS OF MEDICAL CONDITION PAIRS FROM MEPS 2001 AND 2003
  • LEARNING EFFECTS IN EQ-5D TIME TRADE-OFF VALUATIONS
    • Stein, K.
  • NICE DECISION MAKING
    • Stengel, D.
  • PHYSICIAN HEAL THYSELF! WHY DO SURGEONS DECIDE TO IGNORE THEIR OWN HEALTH ADVICE?
    • Stevans, J.
  • THE COST-EFFECTIVENESS OF THREE REFERRAL STRATEGIES FOR ACUTE LOW BACK PAIN IN THE PRIMARY CARE SETTING
    • Stevens, A. S.
  • SHARED DECISION MAKING FOR WOMEN WITH BREAST CANCER: KNOWLEDGE, VALUES, AND DECISIONAL CONFLICT OVER TIME
    • Stevenson, M.
  • DIAGNOSING ALCOHOLIC LIVER DISEASE: A PILOT STUDY FOR NICE
  • CONCURRENT ORAL SESSION D: SIMULATION AND HEALTH TECHNOLOGY ASSESSMENT APPLICATIONS
  • NICE DECISION MAKING
    • Stewart, M.
  • SHARED DECISION MAKING BEHAVIOURS IN FAMILY MEDICINE RESIDENTS
    • Stewart, S. B.
  • ARE THERE GAINS IN COST-EFFECTIVENESS OF CHEMOPREVENTION FOR PROSTATE CANCER WHEN TARGETING MEN AT HIGHER RISK BASED ON FAMILY HISTORY AND GENETIC RISK MARKERS?
    • Steyerberg, E. W.
  • PERSONALIZED PREVENTION OF CORONARY ARTERY DISEASE
    • Stiggelbout, A. M.
  • SCALE RECALIBRATION IN WILLINGNESS TO PAY FOR FINGER SPLINTS IN PATIENTS WITH RHEUMATOID ARTHRITIS
  • FOCUSING ILLUSION AND EQ-5D HEALTH STATE DESCRIPTIONS: PATIENTS VS. PUBLIC
  • CONCURRENT ORAL SESSION B: RISK PERCEPTION
    • Stout, N. K.
  • DESIGNING RISK-TAILORED BREAST CANCER SCREENING POLICIES CONSIDERING IMPERFECT ADHERENCE
    • Stovring, H.
  • ESTIMATING SURIVAL GAINS – CAN WE RELY ON “END-OF-STUDY” RESULTS?
    • Street, R.
  • THE IMPACT OF PATIENT-PHYSICIAN RELATIONSHIP COMPONENTS ON PHYSICIAN TRUST AND TREATMENT ADHERENCE IN PATIENTS WITH RHEUMATIC DISEASE
    • Strickler, G.
  • EFFECTS ON ILLNESS ON CAREGIVERS AND FAMILIES: A REVIEW OF SPILLOVER EFFECTS IN HEALTH
    • Stwalley, D. L.
  • EXTERNAL VALIDATION OF A MODEL OF GLAUCOMA PROGRESSION USING INDIVIDUAL LEVEL DATA
  • DEVELOPMENT OF A MULTIATTRIBUTE INSTRUMENT FOR ESTIMATING UTILITIES (PREFERENCE WEIGHTS) IN PEOPLE WITH GLAUCOMA FROM THE NATIONAL EYE INSTITUTE VISION FUNCTION QUESTIONNAIRE
    • Styron, J. F.
  • DEVELOPING A VALID METHOD OF PREDICTING RETURNING TO WORK FOLLOWING PRIMARY TOTAL KNEE ARTHROPLASTY
    • Su, A.
  • PREDICTION OF CARDIAC OUTCOMES BY PHYSICIANS VS PRACTICE GUIDELINES
    • Suárez, A. M.
  • DIAGNOSTIC ERRORS OF METHODOLOGIC NATURE
    • Suarez-Almazor, M. E.
  • THE IMPACT OF PATIENT-PHYSICIAN RELATIONSHIP COMPONENTS ON PHYSICIAN TRUST AND TREATMENT ADHERENCE IN PATIENTS WITH RHEUMATIC DISEASE
    • Suh, A.
  • PREDICTION OF CARDIAC OUTCOMES BY PHYSICIANS VS PRACTICE GUIDELINES
    • Suk, M.
  • PHYSICIAN HEAL THYSELF! WHY DO SURGEONS DECIDE TO IGNORE THEIR OWN HEALTH ADVICE?
    • Sulit, M. V. V.
  • EFFECTIVENESS OF SHORT MESSAGING SERVICE OF CRITICALLY APPRAISED TOPIC CONCLUSIONS AS A CONTINUING MEDICAL EDUCATION STRATEGY
    • Sullivan, S. D.
  • THE COMPARATIVE EFFECTIVENESS OF BIOMARKERS FOR ALZHEIMER DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
    • Sullivan, T.
  • CANCER SCREENING DECISIONS AND POLICY: WHEN MIXED EVIDENCE MEETS STRONG PREFERENCES
    • Sun, H.
  • COST-EFFECTIVENESS OF NOVEL ANTIRETROVIRALS FOR HUMAN IMMUNODEFICIENCY VIRUS INFECTION
    • Sun, J.
  • ARE THERE GAINS IN COST-EFFECTIVENESS OF CHEMOPREVENTION FOR PROSTATE CANCER WHEN TARGETING MEN AT HIGHER RISK BASED ON FAMILY HISTORY AND GENETIC RISK MARKERS?
    • Sundaram, V.
  • IS THERE A DIFFERENCE BETWEEN ORGANIC AND CONVENTIONAL ANIMAL PRODUCTS? A SYSTEMATIC REVIEW OF THE HEALTH BENEFITS AND HARMS
  • CARE COORDINATION: WHAT WORKS? MAKING SENSE OF A VAST LITERATURE VIA A SYSTEMATIC REVIEW OF REVIEWS
  • IS THERE A DIFFERENCE BETWEEN ORGANICALLY AND CONVENTIONALLY GROWN PRODUCE? A SYSTEMATIC REVIEW OF THE HEALTH BENEFITS AND HARMS
    • Swann, J. L.
  • THE IMPACT OF MASS CHANGES IN SOCIAL MIXING PATTERNS ON THE COURSE OF AN INFLUENZA PANDEMIC
  • SUPPLY CHAIN AND SYSTEM FACTORS THAT EXPLAIN VARIATIONS IN STATE VACCINATION COVERAGE LEVELS OF THE NOVEL H1N1 VACCINE
    • Sy, S.
  • MODELING HISTORICAL TRENDS IN CERVICAL CANCER USING A MULTI-COHORT MODEL
    • A B C D E F G H I J K L M N O P Q R S T U V W X Y Z